Cigna free cash flow CI
Cash from operations less capital spending, by quarter and over the last twelve months, from 2008.
- Last 12 months, to Dec 31, 2019
- $8.4B
- Latest quarter, Q4 FY19
- $2.5B
- Fiscal year 2019
- $8.4B
- +160% on the year before
Cigna's free cash flow was $8.4B over the twelve months to Dec 31, 2019, up 160% on a year earlier.
In its latest quarter, Q4 FY19, it was $2.5B.
Over the five fiscal years to FY2019 it grew 41% a year on average.
Free cash flow over time
Fiscal year by fiscal year
| Fiscal year | Free cash flow | Change |
|---|---|---|
| FY2019 | $8.4B | +160% |
| FY2018 | $3.2B | −10% |
| FY2017 | $3.6B | +1% |
| FY2016 | $3.6B | +47% |
| FY2015 | $2.4B | +59% |
| FY2014 | $1.5B | +692% |
| FY2013 | $192M | −90% |
| FY2012 | $1.9B | +82% |
| FY2011 | $1.1B | −26% |
| FY2010 | $1.4B | +229% |
| FY2009 | $438M | n/a |
| FY2008 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Free cash flow | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY19 | $2.5B | n/a | $8.4B | |
| Q3 FY19 | $2.2B | +345% | $5.9B | |
| Q2 FY19 | $736M | −16% | $4.2B | |
| Q1 FY19 | $3B | +56% | $4.3B | |
| Q4 FY18 | −$56M | −113% | $3.2B | |
| Q3 FY18 | $498M | −54% | $3.7B | |
| Q2 FY18 | $878M | +48% | $4.3B | |
| Q1 FY18 | $1.9B | +29% | $4B | |
| Q4 FY17 | $444M | −41% | $3.6B | |
| Q3 FY17 | $1.1B | −40% | $3.9B | |
| Q2 FY17 | $594M | +191% | $4.6B | |
| Q1 FY17 | $1.5B | +84% | $4.2B |
Against its peers
Companies in Medical - Healthcare Plans nearest Cigna's size, closest first, today.
| Company | Free cash flow yield |
|---|---|
| CICigna | n/m |
| ELVElevance Health | 6.6% |
| CVSCVS Health | 9.8% |
| HUMHumana | 3.8% |
| CNCCentene | 25.8% |
| UNHUnitedHealth | n/m |
| OSCROscar Health | n/m |
| Peer median | 8.2% |
What the free cash flow tells you
Cash from operations minus capital spending. The cash the company could hand back or reinvest.
Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.
More on Cigna
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.